Covered recipient · General Payments record
NORA S LEE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2022
$621.63
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $154.80 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | $54.52 | 4 |
| Supernus Pharmaceuticals, Inc. | $35.73 | 2 |
| Neurocrine BioSciences, Inc. | $27.68 | 1 |
| Avanir Pharmaceuticals, Inc. | $21.45 | 1 |
| Amneal Pharmaceuticals LLC | $15.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | $15.42 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956585107 | CMS |
| Avanir Pharmaceuticals, Inc. | $21.45 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935928723 | CMS |
| Neurocrine Biosciences, Inc. | $27.68 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963316947 | CMS |
| Sunovion Pharmaceuticals Inc. | $8.64 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921125891 | CMS |
| Sunovion Pharmaceuticals Inc. | $14.11 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921063873 | CMS |
| Sunovion Pharmaceuticals Inc. | $14.27 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921061753 | CMS |
| Sunovion Pharmaceuticals Inc. | $17.50 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921018329 | CMS |
| Supernus Pharmaceuticals, Inc. | $20.41 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952992333 | CMS |
| Supernus Pharmaceuticals, Inc. | $15.32 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952992337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022
- Source files
- Dataset page · Bulk file · PY2019 , PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.